A systematic evaluation of seven different scores representing the EAT-Lancet reference diet and mortality, stroke, and greenhouse gas emissions in three cohorts.


Journal

The Lancet. Planetary health
ISSN: 2542-5196
Titre abrégé: Lancet Planet Health
Pays: Netherlands
ID NLM: 101704339

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 21 04 2023
revised: 23 02 2024
accepted: 18 04 2024
medline: 8 6 2024
pubmed: 8 6 2024
entrez: 7 6 2024
Statut: ppublish

Résumé

Different approaches have been used for translation of the EAT-Lancet reference diet into dietary scores that can be used to assess health and environmental impact. Our aim was to compare the different EAT-Lancet diet scores, and to estimate their associations with all-cause mortality, stroke incidence, and greenhouse gas emissions. We did a systematic review (PROSPERO, CRD42021286597) to identify different scores representing adherence to the EAT-Lancet reference diet. We then qualitatively compared the diet adherence scores, including their ability to group individuals according the EAT-Lancet reference diet recommendations, and quantitatively assessed the associations of the diet scores with health and environmental outcome data in three diverse cohorts: the Danish Diet, Cancer and Health Cohort (DCH; n=52 452), the Swedish Malmö Diet and Cancer Cohort (MDC; n=20 973), and the Mexican Teachers' Cohort (MTC; n=30 151). The DCH and MTC used food frequency questionnaires and the MDC used a modified diet history method to assess dietary intake, which we used to compute EAT-Lancet diet scores and evaluate the associations of scores with hazard of all-cause mortality and stroke. In the MDC, dietary greenhouse gas emission values were summarised for every participant, which we used to predict greenhouse gas emissions associated with varying diet adherence scores on each scoring system. In our review, seven diet scores were identified (Knuppel et al, 2019; Trijsburg et al, 2020; Cacau et al, 2021; Hanley-Cook et al, 2021; Kesse-Guyot et al, 2021; Stubbendorff et al, 2022; and Colizzi et al, 2023). Two of the seven scores (Stubbendorff and Colizzi) were among the most consistent in grouping participants according to the EAT-Lancet reference diet recommendations across cohorts, and higher scores (greater diet adherence) were associated with decreased risk of mortality (in the DCH and MDC), decreased risk of incident stroke (in the DCH and MDC for the Stubbendorff score; and in the DCH for the Colizzi score), and decreased predicted greenhouse gas emissions in the MDC. We conclude that the seven different scores representing the EAT-Lancet reference diet had differences in construction, interpretation, and relation to disease and climate-related outcomes. Two scores generally performed well in our evaluation. Future studies should carefully consider which diet score to use and preferably use multiple scores to assess the robustness of estimations, given that public health and environmental policy rely on these estimates.

Identifiants

pubmed: 38849181
pii: S2542-5196(24)00094-9
doi: 10.1016/S2542-5196(24)00094-9
pii:
doi:

Substances chimiques

Greenhouse Gases 0

Types de publication

Journal Article Systematic Review Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e391-e401

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests AS, UE, and ES were all involved in constructing one of the EAT–Lancet diet scores investigated (Stubbendorff et al(8)). All other authors declare no competing interests.

Auteurs

Anna Stubbendorff (A)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Electronic address: anna.stubbendorff@med.lu.se.

Dalia Stern (D)

CONAHCyT-Center for Population Health Research, National Institute of Public Health, Avenida Universidad 655, Cuernavaca, Mexico.

Ulrika Ericson (U)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Emily Sonestedt (E)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Elinor Hallström (E)

Department of Agriculture and Food, Research Institutes of Sweden, Lund, Sweden.

Yan Borné (Y)

Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Martin Lajous (M)

CONAHCyT-Center for Population Health Research, National Institute of Public Health, Avenida Universidad 655, Cuernavaca, Mexico.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.

Anja Olsen (A)

Department of Public Health, Aarhus University, Aarhus, Denmark; Danish Cancer Society, Copenhagen, Denmark.

Christina C Dahm (CC)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Daniel B Ibsen (DB)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus Denmark; Department of Nutrition, Sports and Exercise, University of Copenhagen, Frederiksberg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH